Atorvastatin fails to slow aortic dilatation and valvular calcification progression in bicuspid aortic valve: BICATOR Trial Medha Baranwal7 Jun 2024 9:30 AM ISTSpain: In a significant stride toward managing aortic health, a recent randomized clinical trial, BICATOR (Bicuspid Aortic Valve), has uncovered...
Mean Arterial Pressure Linked to Neonatal Outcomes in Pregnancies with Mild Chronic Hypertension: Study Medha Baranwal7 Jun 2024 9:00 AM ISTUSA: A recent study published in Obstetrics and Gynecology has found that increasing mean arterial pressure (MAP) is positively associated with most...
Narcolepsy may be a risk factor for cardiovascular disease and adverse cardiac events, study finds Anshika Mishra7 Jun 2024 8:30 AM ISTTwo new studies to be presented at the SLEEP 2024 annual meeting showed that narcolepsy is an independent risk factor for cardiovascular disease and...
Energy Drinks Linked to Dangerous Cardiac Arrhythmias in Patients with Genetic Heart Diseases: Study Anshika Mishra7 Jun 2024 8:00 AM ISTA new study, published in Heart Rhythm, examined the potential dangers of consuming energy drinks for patients with genetic heart diseases.Energy...
Excess Apolipoprotein B closely associated with cardiovascular risks: JACC Jacinthlyn Sylvia6 Jun 2024 9:45 AM ISTA recent large-scale study published in the Journal of the American College of Cardiology highlighted the critical role of apolipoprotein B (apoB) in...
Prasad Hospitals performs TAVI Procedure to repair heart valve in 79-year-old patient Kajal Rajput6 Jun 2024 9:30 AM ISTHyderabad: Prasad Hospitals, a rapidly expanding network of four hospitals providing premium healthcare at an affordable cost in Hyderabad,...
Oral PCSK9 inhibitor, AZD0780 demonstrates significant Reduction of LDL-C in Hypercholesterolemia patients in phase 1 trial Dr. Kamal Kant Kohli5 Jun 2024 10:00 AM ISTPositive results from a Phase I trial of AZD0780, an oral small molecule PCSK9 inhibitor administered on top of statin treatment, were presented at...
Plozasiran: Groundbreaking RNA Interference Agent Targets APOC3 for Mixed Hyperlipidemia suggests research Medha Baranwal5 Jun 2024 10:00 AM ISTUSA: In a groundbreaking development in lipid management, researchers have unveiled a promising RNA interference (RNAi) agent known as Plozasiran....
Single COVID-19 vaccine dose fails to reduce major adverse CV events after acute coronary syndromes: JAMA Dr Riya Dave5 Jun 2024 9:45 AM ISTResearchers have found that COVID-19 vaccines did not significantly reduce the incidence of cardiopulmonary events in high-risk cardiovascular...
New postpartum care recommentheions of AHA target CVD risk Dr. Kamal Kant Kohli5 Jun 2024 7:00 AM ISTPregnancy-related deaths in the U.S. have risen 140% over the past three decades and cardiovascular disease is the leading cause. Despite existing...
Hot flashes in menopausal women may signal increased risk for heart and metabolic issues, reveals study Dr. Kamal Kant Kohli4 Jun 2024 10:00 PM ISTWomen experiencing moderate-to-severe vasomotor symptoms face a three times greater risk for metabolic-dysfunction-associated steatotic liver disease...
Metabolic and Bariatric Surgery Shows Promising Impact on Apo B100 Levels in High BMI Individuals: Multi-Centric Study Medha Baranwal4 Jun 2024 8:45 PM ISTIran: In a groundbreaking multi-centric prospective cohort study, researchers have shed light on the transformative impact of metabolic and bariatric...
